Paul Tudor Jones Keros Therapeutics, Inc. Transaction History
Tudor Investment Corp Et Al
- $25.1 Billion
- Q4 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 15,331 shares of KROS stock, worth $172,013. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,331
Previous 19,787
22.52%
Holding current value
$172,013
Previous $1.15 Million
78.94%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding KROS
# of Institutions
177Shares Held
31.1MCall Options Held
646KPut Options Held
670K-
Black Rock Inc. New York, NY2.51MShares$28.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.96MShares$22 Million0.0% of portfolio
-
Braidwell LP Stamford, CT1.89MShares$21.3 Million1.68% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y91.69MShares$18.9 Million2.53% of portfolio
-
State Street Corp Boston, MA1.2MShares$13.5 Million0.0% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $289M
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...